Skip to main content
SpringerLink
Log in

Cardiac resynchronisation therapy in heart failure: Current status

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Cardiac resynchronization in heart failure already has a history of 12 years. However, the major advances have been the result of large multi center trials dating from 2001. In all these trials patients with a LVEF ≤ 35% were included, and a QRS above 120 msec. Follow up was from 3–36 months. The majority of these trials showed a positive effect in reduction of composite and points of death or hospitalization for major cardiovascular events. Many of these trials also showed a diminution of left ventricular and systolic diameter or volume. Even in NYHA class II patients an improvement was seen. Some unanswered questions still remain as regards the agreement on electrical or electromechanical dyssynchrony criteria. There is a number of patients with “wide” QRS who do not improve and conversely a number of patients with a narrow QRS who witness improvement. The benefit in patients with atrial fibrillation also remains unanswered. Finally the value of this modality in patients with mild heart failure or asymptomatic left ventricular systolic dysfunction, NYHA class I–II remains to be determined in large on going trials. Another question is whether biventricular or left ventricular patient is preferable. Finally whether biventricular patient should be complemented by a defibrillator insertion is being currently studied. Cardiac resynchronization therapy along or in combination with an ICD improves symptoms, reduces major morbidity and mortality in patients with a left ventricular EF<35%, ventricular dilatation and a QRS ≥ 120 msec in NYHA class III–IV. Further indications are currently being examined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vagnini FJ, Gourin A, Antell HI, Stuckey JH. Implantation sites of cardiac pacemaker electrodes and myocardial contractility. Ann Thorac Surg 1967;4(5):431–9.

    Article  PubMed  CAS  Google Scholar 

  2. Tyers GF. Comparison of the effect on cardiac function of single-site and simultaneous multiple-site ventricular stimulation after A-V block. J Thorac Cardiovasc Surg 1970;59(2):211–7.

    PubMed  CAS  Google Scholar 

  3. Gibson DG, Chamberlain DA, Coltart DJ, Mercer J. Effect of changes in ventricular activation on cardiac haemodynamics in man. Comparison of right ventricular, left ventricular, and simultaneous pacing of both ventricles. Br Heart J 1971;33(3):397–400.

    PubMed  CAS  Google Scholar 

  4. De Teresa E, Chamoro JL, Pupon A. An even more physiological pacing: changing the sequence of ventricular acxtivation. In E Steinbach (Eds), Proccedings of the VIIth world congress on cardiac pacing. Vienna, Austria, 1983, pp. 95–100.

  5. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974–1979.

    Article  PubMed  CAS  Google Scholar 

  6. Bakker P, Meijburg H, De Jonghe N, et al. Beneficial effects of biventricular pacing in congestive heart failure. Pacing Clin Electrophysiol 1994;17:820(abstract).

    Google Scholar 

  7. Vernooy K, Verbeek XAAM, Peschar M, et al. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 2005;26:91–98.

    Article  PubMed  Google Scholar 

  8. Spragg DD, Leclercq, Loghmani M, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 2003;108:929–932.

    Article  PubMed  CAS  Google Scholar 

  9. Nowak B, Sinha A, Schaefer W, et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003;41:1523–28.

    Article  PubMed  Google Scholar 

  10. Ukkonenen H, Beanlands R, Burwash I, et al. Effect of cardiac resynchronization on myocardial efficiency and regioanl oxidative metabolism. Circulation 2003;107:28–31.

    Article  CAS  Google Scholar 

  11. Sundell J, Engblom E, Koistinen J, et al. The effects of cardiac resynchronization therapy on left vnetricular function? myocardial energetics? and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004;43:1027–1033.

    Article  PubMed  Google Scholar 

  12. Alonso C, Leclercq C, Victor F, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999;84:1417–21.

    Article  PubMed  CAS  Google Scholar 

  13. Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140:862–870.

    Article  PubMed  CAS  Google Scholar 

  14. Bakker PF, Meijburg H, de Vries JW, et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Intervent Card Electrophysiol 2000;4:395–404.

    Article  CAS  Google Scholar 

  15. Ricci R, Ansalone G, Tosacano S, et al. Cardiac resynchronization: Materials, technique, and results. The InSync Italian Registry. Eur Heart J 2000;2:J6–15.

    Google Scholar 

  16. Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311–320.

    Article  PubMed  Google Scholar 

  17. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.

    Article  PubMed  CAS  Google Scholar 

  18. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  19. Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–2033.

    Article  PubMed  Google Scholar 

  20. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109–16.

    Article  PubMed  Google Scholar 

  21. Higgins S, Hummel J, Niazi I, et al. Cardiac resynchronization therapy for the treatment of herat failure in patients with intraventricualr conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454–9.

    Article  PubMed  Google Scholar 

  22. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioverter defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003;289:2685–2694.

    Article  PubMed  Google Scholar 

  23. Abraham WT, Young JB, Leon AR, et al. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular dysfunction, an indication for an implantable cardioverter-defibrillator, and midly symptomatic heart failure. Circulation 2004;110:2864–2868.

    Article  PubMed  Google Scholar 

  24. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.

    Article  PubMed  CAS  Google Scholar 

  25. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization therapy on morbidity and mortality in heart failure (the CArdiac REsynchronization-Heart Failure [CARE-HF] Trial). N Eng J Med 2005;352:1539–1549.

    Article  CAS  Google Scholar 

  26. Bradley D, Bradley E, Baughmann, et al. Cardiac resynchronization and death from progressive heart failure. JAMA 2003;289:730–740.

    Article  PubMed  Google Scholar 

  27. Mc Alister EA, Ezekowitz JA, Wiebe N, et al. Systematic review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 200';141:381–390.

  28. Linde C, Leclercq C, Rex S, et al. Long-terms benefits of biventricular pacing in congestive heart failure: Results from the MUSTIC study. J Am Coll Cardiol 2002;40:111–118.

    Article  PubMed  Google Scholar 

  29. Duncan A, Wait D, Gibson D, et al. Left ventricular remodeling and hemodynamic effects of multisite pacing in patients with left systolic dysfunction and activation disturbances in sinus rhythm: Sub-study of the MUSTIC trial. Eur Heart J 2003;24:430–441.

    Article  PubMed  CAS  Google Scholar 

  30. Stellbrink C, Breithardt, O, Franke A. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957–1965.

    Article  PubMed  CAS  Google Scholar 

  31. St John Sutton M, Plappert T, Abraham W, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985–1990.

    Article  Google Scholar 

  32. Braunschweig F, Linde C, Gadler F, et al. Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2000;24:399–406.

    Article  Google Scholar 

  33. Curnis A, Caprari F, Mascioli G. Biventricular resynchronization: Cost and effectiveness analysis. Pharmacoeconomics 2003;5:11–22.

    Google Scholar 

  34. Leclercq C, Hare J. Ventricular resynchronization. Current state of the art. Circulation 2004;10:296–299.

    Article  Google Scholar 

  35. Freemantle N on behalf of the CARE-HF Investigators. Cost-Effectiveness of Cardiac Resynchronisation Therapy (Results of the main study). Presentation in the Clinical Trials Update II session, ESC congress, Stockholm, Sept 7, 2005 (on-line: http://www.escardio.org).

  36. Bleeker G, Schalij, Molhoek S, et al. Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex. Am J Cardiol 2005;95:140–142.

    Article  PubMed  Google Scholar 

  37. Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dysynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004;25:571–578.

    Article  PubMed  Google Scholar 

  38. Bader H, Garrigue S, Lafitte S, et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248–256.

    Article  PubMed  Google Scholar 

  39. Bax J, Bleeker JB, Molhoek SG, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardilo; 2004;44:1834–1840.

    Article  Google Scholar 

  40. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory herat failure and narrow QRS. J Am Coll Cardiol 2003;42:2117–2124.

    Article  PubMed  Google Scholar 

  41. Gasparini M, Mantica M, Galimberti P, et al. Beneficial effects of biventricular pacing in patients with a narrow QRS. Pacing Clin Electrophysiol 2003;26:169–174

    Article  PubMed  Google Scholar 

  42. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J 2002;143:398–405.

    Article  PubMed  Google Scholar 

  43. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780–1787.

    Article  PubMed  CAS  Google Scholar 

  44. Brignole F, Gammage M, Puggioni E, et al. Comparative assessment of right, left, and bivnetricular pacing in patients with permanent atrial fibrillation. Eur Heart J 2005;7:712–722.

    Article  Google Scholar 

  45. Post AV Nodal Ablation Evaluation (PAVE) trial. http://www.heartrhythmfoundation.org/research/pave/default.asp

  46. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling: Concept and clinical implications. A consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol 2000;35:569–582.

    Article  PubMed  CAS  Google Scholar 

  47. Bardy G, Lee KL, Mark DB, et al. (SCD-HeFT study).Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–237.

    Article  PubMed  CAS  Google Scholar 

  48. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7:176–182.

    Article  PubMed  CAS  Google Scholar 

  49. Linde C, Abraham W, Gold M, Daubert C. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic or mild heart failure: the REVERSE study. Am Heart J (2005, in press).

  50. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: Results of an acute hemodynamic study. Circulation 1997;96:3273–3277.

    PubMed  CAS  Google Scholar 

  51. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567–1573.

    PubMed  CAS  Google Scholar 

  52. Leclercq C, Faris O, Tunin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002;106:1760–1763

    Article  PubMed  Google Scholar 

  53. Blanc JJ, Bertaut-Valls V, Fatemi M, et al. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 2004 13;109:1741–1744.

    Article  PubMed  Google Scholar 

  54. De Lurgio DB, Foster E, Higginbotham MB, Larntz K, Saxon LA. A comparison of cardiac resynchronisation therapy by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: Rationale and design of the DECREASE-HF clinical trial. J Cardiac Failure 2005;11:233–239.

    Article  Google Scholar 

  55. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL, Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001–2007.

    Google Scholar 

  56. Swedberg K, Cleland JGF, Dargie H, et al. Task Force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: update 2005. Eur Heart J 2005;2005;26:1115–1140.

    Article  PubMed  CAS  Google Scholar 

  57. St. John Sutton MG, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodelling with cardiac resynchronization at one year is a function of etiology. Circulation 2006;113:266–272.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Cardiologie et Maladies vasculaires, CHU Rennes, France

    J. Claude Daubert, Christophe Leclercq, Erwan Donal & Philippe Mabo

Authors
  1. J. Claude Daubert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christophe Leclercq
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erwan Donal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philippe Mabo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daubert, J.C., Leclercq, C., Donal, E. et al. Cardiac resynchronisation therapy in heart failure: Current status. Heart Fail Rev 11, 147–154 (2006). https://doi.org/10.1007/s10741-006-9485-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-006-9485-9

Keywords

Search

Navigation